The effect of dexmedetomidine on emergence agitation in children undergoing a surgery under desflurane anesthesia.

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CRIS

Registry ID

KCT0000141

Enrollment

112

Registered

2011-07-07

Start date

2013-02-28

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : There are four groups accoding to dosage of dexmedetomidine. Dexmedetomidine 0.25 microg.kg&#40

-1&#41

,&#40

group D0.25&#41

, dexmedetomidine 0.5 microg.kg&#40

Group D0.5&#41

, dexmedetomidine 1 microg.kg&#40

&#40

Group D 1&#41

and normal saline&#40

group P&#41

is administered ivs. for 10mins when we are inducing each patient.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Physical status classification of American Society of Anesthesiologist 1-2, healthy, normal, 2-6 years old, elective operation

Exclusion criteria

Exclusion criteria: lack of consent, known adverse effects to dexmedetomidine, mental retardation, developmental delay, or neurological or psychiatric illness that may associate with agitation (cerebral palsy, seizure, etc), no cardiac disease

Design outcomes

Primary

Measure	Time frame
Agitation score	—

Secondary

Measure	Time frame
Oculomotor reflex	—

Countries

Korea, Republic of

Contacts

Public ContactAh-young Oh

Seoul National University Bundang Hospital

Outcome results